Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Pneumonologia Polska
MENU
Na skróty Zdeponuj artykuł Wytyczne dla autorów

Tom 4, Nr 4 (2023)
Artykuł przeglądowy
Wysłany: 2023-11-07
Opublikowany online: 2024-02-12
Dodaj do koszyka: 49,00 PLN
Pobierz cytowanie

Dym palonego drewna — efekty zdrowotne

Paweł Górski1
DOI: 10.5603/pp.98151
·
Pneum Pol 2023;4(4):145-152.
Afiliacje
  1. Klinika Pneumonologii, II Katedra Chorób Wewnętrznych, Uniwersytet Medyczny w Łodzi

dostęp płatny

Tom 4, Nr 4 (2023)
PRACE POGLĄDOWE
Wysłany: 2023-11-07
Opublikowany online: 2024-02-12

Streszczenie

Dym spalanego drewna stanowi najważniejszy rodzaj narażenia na biomasę w domach polskich. Przyczyną tego stanu jest coraz częstsze używanie kominków do ogrzewania mieszkań. Dym palonego drewna jest przyczyną przewlekłej choroby obturacyjnej płuc (POChP), raka płuc i chorób układu sercowo-naczyniowego. Zmiany patologiczne wywołane przez dym palonego drewna różnią się od zmian spowodowanych nałogiem tytoniowym. Także obraz kliniczny POChP w następstwie tych ekspozycji jest różny, choć w zakresie farmakoterapii postępowanie jest identyczne.

Streszczenie

Dym spalanego drewna stanowi najważniejszy rodzaj narażenia na biomasę w domach polskich. Przyczyną tego stanu jest coraz częstsze używanie kominków do ogrzewania mieszkań. Dym palonego drewna jest przyczyną przewlekłej choroby obturacyjnej płuc (POChP), raka płuc i chorób układu sercowo-naczyniowego. Zmiany patologiczne wywołane przez dym palonego drewna różnią się od zmian spowodowanych nałogiem tytoniowym. Także obraz kliniczny POChP w następstwie tych ekspozycji jest różny, choć w zakresie farmakoterapii postępowanie jest identyczne.

Pełny tekst:

Dodaj do koszyka: 49,00 PLN
Pobierz cytowanie

Słowa kluczowe

biomasa, dym palonego drewna, POChP, mechanizmy, obraz kliniczny

Informacje o artykule
Tytuł

Dym palonego drewna — efekty zdrowotne

Czasopismo

Pneumonologia Polska

Numer

Tom 4, Nr 4 (2023)

Typ artykułu

Artykuł przeglądowy

Strony

145-152

Opublikowany online

2024-02-12

Wyświetlenia strony

74

Wyświetlenia/pobrania artykułu

5

DOI

10.5603/pp.98151

Rekord bibliograficzny

Pneum Pol 2023;4(4):145-152.

Słowa kluczowe

biomasa
dym palonego drewna
POChP
mechanizmy
obraz kliniczny

Autorzy

Paweł Górski

Referencje (66)
  1. World Health Organization. Household air pollution and health. https//www.who.int/news-room/fact-sheets/detail/househeld-air-pollution-health.
  2. Eisner MD, Anthonisen N, Coultas D, et al. Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182(5): 693–718.
    CrossRefPubMed
  3. Adeloye D, Song P, Zhu Y, et al. NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022; 10(5): 447–458.
    CrossRefPubMed
  4. Hu G, Zhou Y, Tian J, et al. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest. 2010; 138(1): 20–31.
    CrossRefPubMed
  5. Kurmi OmP, Semple S, Simkhada P, et al. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010; 65(3): 221–228.
    CrossRefPubMed
  6. Smith KR, Mehta S, Maeusezahl-Feuz M. Indoor smoke from household solid fuels. In: Maeusezahl-Feuz M. ed. Comparative quantification of health risks: Global and regional burden of disease due to selected major risk factors. World Health Organization., Geneva Switzerland 2004: 1435–1493.
  7. Fullerton DG, Suseno A, Semple S, et al. Wood smoke exposure, powerty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis. 2011; 15: 391–398.
  8. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 201: systematic analysis of population health data. Lancet. 2006; 367: 1147–1157.
  9. Balmes JR. When smoke gets in your lungs. Proc Am Thorac Soc. 2010; 7(2): 98–101.
    CrossRefPubMed
  10. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014; 2(10): 823–860.
    CrossRefPubMed
  11. Sana A, Somda SMA, Meda N, et al. Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis. BMJ Open Respir Res. 2018; 5(1): e000246.
    CrossRefPubMed
  12. Çolak Y, Marott JL, Vestbo J, et al. Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study. COPD. 2015; 12(1): 5–13.
    CrossRefPubMed
  13. Al Ghobain M. The effect of obesity on spirometry tests among healthy non-smoking adults. BMC Pulm Med. 2012; 12: 10.
    CrossRefPubMed
  14. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 160(6): 1856–1861.
    CrossRefPubMed
  15. Ji Z, de Miguel-Díez J, Castro-Riera CR, et al. Differences in the Outcome of Patients with COPD according to Body Mass Index. J Clin Med. 2020; 9(3): 710.
    CrossRefPubMed
  16. Matsunaga K, Harada M, Suizu J, et al. Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs. J Clin Med. 2020; 9(10).
    CrossRefPubMed
  17. Zhou Y, Wang D, Liu S, et al. The association between BMI and COPD: the results of two population-based studies in Guangzhou, China. COPD. 2013; 10(5): 567–572.
    CrossRefPubMed
  18. White AJ, Sandler DP. Indoor Wood-Burning Stove and Fireplace Use and Breast Cancer in a Prospective Cohort Study. Environ Health Perspect. 2017; 125(7): 077011.
    CrossRefPubMed
  19. Rokoff LB, Koutrakis P, Garshick E, et al. Wood Stove Pollution in the Developed World: A Case to Raise Awareness Among Pediatricians. Curr Probl Pediatr Adolesc Health Care. 2017; 47(6): 123–141.
    CrossRefPubMed
  20. Chen J, Hoek G. Long-term exposure to PM and all-cause and cause-specific mortality: A systematic review and meta-analysis. Environ Int. 2020; 143: 105974.
    CrossRefPubMed
  21. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 119. IARC 2019.
  22. Shupler M, Hystad P, Birch A, et al. PURE-AIR study. Household and personal air pollution exposure measurements from 120 communities in eight countries: results from the PURE-AIR study. Lancet Planet Health. 2020; 4(10): e451–e462.
    CrossRefPubMed
  23. Rehfuess E. World Health Organization. Fuel for life: Household energy and health.
  24. Nicolaou L, Fandiño-Del-Rio M, Koehler K, et al. Size distribution and lung-deposited doses of particulate matter from household exposure to biomass smoke. Indoor Air. 2021; 31(1): 51–62.
    CrossRefPubMed
  25. Ortiz-Quintero B, Martínez-Espinosa I, Pérez-Padilla R. Mechanisms of Lung Damage and Development of COPD Due to Household Biomass-Smoke Exposure: Inflammation, Oxidative Stress, MicroRNAs, and Gene Polymorphisms. Cells. 2022; 12(1).
    CrossRefPubMed
  26. U.S. Environmental Protection Agency. Strategies for reducing residential wood smoke. Office of Air QualityPlanning and Standards. Research Triangle Park, NC 2013.
  27. Ward TJ, Semmens EO, Weiler E, et al. Efficacy of interventions targeting household air pollution from residential wood stoves. J Expo Sci Environ Epidemiol. 2017; 27(1): 64–71.
    CrossRefPubMed
  28. Wheeler AJ, Gibson MD, MacNeill M, et al. Impacts of air cleaners on indoor air quality in residences impacted by wood smoke. Environ Sci Technol. 2014; 48(20): 12157–12163.
    CrossRefPubMed
  29. Walker ES, Semmens EO, Belcourt A, et al. Efficacy of Air Filtration and Education Interventions on Indoor Fine Particulate Matter and Child Lower Respiratory Tract Infections among Rural U.S. Homes Heated with Wood Stoves: Results from the KidsAIR Randomized Trial. Environ Health Perspect. 2022; 130(4): 47002.
    CrossRefPubMed
  30. Walker ES, Noonan CW, Semmens EO, et al. Indoor fine particulate matter and demographic, household, and wood stove characteristics among rural US homes heated with wood fuel. Indoor Air. 2021; 31(4): 1109–1124.
    CrossRefPubMed
  31. Ocakli B, Acarturk E, Aksoy E, et al. The impact of exposure to biomass smoke versus cigarette smoke on inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018; 13: 1261–1267.
    CrossRefPubMed
  32. Mahesh PA, Jayraj BS, Prabhakar AK, et al. Identification of a threshold for biomass exposure index for chronic bronchitis in rural women of Mysore district, Karnataka, India. Indian J Med. 2013; 137(1): 87–94.
    PubMed
  33. Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023; 61(4).
    CrossRefPubMed
  34. Shah A, Shah U, Jayalaksami TK, et al. COPD phenotypes according to high resolution CT scan findings. ERJ. 2014; 44(Suppl 58): 3001.
  35. Ramirez A, Sansores R, Velazquez M, et al. Nonsmoker and Biomass Exposure, in Controversies in COPD. ERS monograph SheffieldUK. 2015: 35–45.
  36. Nicolaou L, Checkley W. Differences between cigarette smoking and biomass smoke exposure: An in silico comparative assessment of particulate deposition in the lungs. Environ Res. 2021; 197: 111116.
    CrossRefPubMed
  37. Rivera R, Cosio M, Ghezzo H, et al. Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis. 2008; 12(8): 972–977.
    PubMed
  38. Perez-Rubio G, Ambrocio-Ortiz E, Lopez-Flores LA, et al. Heterozygous Genotype rs17580(PiS) in Serpina I is Associated with COPD Secondary to Biomass-Burning and Tobacco Smoking: A case-control and Population Study. Int J Chron Obstruct Pulm Dis. 2020; 15: 1181–1190.
    CrossRefPubMed
  39. Tan WS, Shen HM, Wong WS. Dysregulated autophagy in COPD: A pathogenic process to be deciphered. Pharmacol Res. 2019; 144: 1–7.
    CrossRefPubMed
  40. Majorek K, Krzyżosiak WJ. Rola mikroRNA w patogenezie, diagnostyce i terapii nowotworów. Współczesna Onkologia. 2006; 10(8): 359–366.
  41. Velasco-Torres Y, Ruiz V, Montaño M, et al. Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass. Biomolecules. 2019; 9(12).
    CrossRefPubMed
  42. Golpe R, Martín-Robles I, Sanjuán-López P, et al. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12: 2639–2646.
    CrossRefPubMed
  43. Velasco-Torres Y, Ruiz-López V, Pérez-Bautista O, et al. miR-34a in serum is involved in mild-to-moderate COPD in women exposed to biomass smoke. BMC Pulm Med. 2019; 19(1): 227.
    CrossRefPubMed
  44. Dickens JA, Lomas DA. CC-16 as a biomarker in chronic obstructive pulmonary disease. COPD. 2012; 9(5): 574–575.
    CrossRefPubMed
  45. Lomas DA, Silverman EK, Edwards LD, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax. 2008; 63(12): 1058–1063.
    CrossRefPubMed
  46. Rava M, Tares L, Lavi I, et al. Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general population. J Allergy Clin Immunol. 2013; 132(1): 230–232.
    CrossRefPubMed
  47. Veerapaneni VV, Upadhyay S, Thimraj TA, et al. Circulating Secretoglobin Family 1A Member 1 (SCGB1A1) Levels as a Marker of Biomass Smoke Induced Chronic Obstructive Pulmonary Disease. Toxics. 2021; 9(9).
    CrossRefPubMed
  48. Lee JH, Song S, Yoon SY, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as diagnostic markers for pneumonia severity. Br J Biomed Sci. 2016; 73(3): 140–142.
    CrossRefPubMed
  49. Białas AJ, Pedone C, Piotrowski WJ, et al. Platelet distribution width as a prognostic factor in patients with COPD - pilot study. Int J Chron Obstruct Pulmon Dis. 2017; 12: 2261–2267.
    CrossRefPubMed
  50. Ramírez-Venegas A, Sansores R, Quintana-Carrillo R, et al. FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease Associated with Biomass Exposure. Am J Respir Crit Care Med. 2014; 190(9): 996–1002.
    CrossRefPubMed
  51. Golpe R, Martín-Robles I, Sanjuán-López P, et al. Prevalence of Major Comorbidities in Chronic Obstructive Pulmonary Disease Caused by Biomass Smoke or Tobacco. Respiration. 2017; 94(1): 38–44.
    CrossRefPubMed
  52. Cho J, Lee CH, Hwang SS, et al. KOLD and KOCOSS Investigators. Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke. BMC Pulm Med. 2019; 19(1): 68.
    CrossRefPubMed
  53. Salvi SS, Brashier BB, Londhe J, et al. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res. 2020; 21(1): 50.
    CrossRefPubMed
  54. Falfán-Valencia R, Ramírez-Venegas A, Pérez Lara-Albisua JL, et al. Smoke exposure from chronic biomass burning induces distinct accumulative systemic inflammatory cytokine alterations compared to tobacco smoking in healthy women. Cytokine. 2020; 131: 155089.
    CrossRefPubMed
  55. Dutta A, Roychoudhury S, Chowdhury S, et al. Changes in sputum cytology, airway inflammation and oxidative stress due to chronic inhalation of biomass smoke during cooking in premenopausal rural Indian women. Int J Hyg Environ Health. 2013; 216(3): 301–308.
    CrossRefPubMed
  56. Dutta A, Ray MR, Banerjee A. Systemic inflammatory changes and increased oxidative stress in rural Indian women cooking with biomass fuels. Toxicol Appl Pharmacol. 2012; 261(3): 255–262.
    CrossRefPubMed
  57. Muala A, Rankin G, Sehlstedt M, et al. Acute exposure to wood smoke from incomplete combustion--indications of cytotoxicity. Part Fibre Toxicol. 2015; 12: 33.
    CrossRefPubMed
  58. Stockfelt L, Sallsten G, Almerud P, et al. Short-term chamber exposure to low doses of two kinds of wood smoke does not induce systemic inflammation, coagulation or oxidative stress in healthy humans. Inhal Toxicol. 2013; 25(8): 417–425.
    CrossRef
  59. Forchhammer L, Møller P, Riddervold IS, et al. Controlled human wood smoke exposure: oxidative stress, inflammation and microvascular function. Part Fibre Toxicol. 2012; 9: 7.
    CrossRefPubMed
  60. Fedak KM, Good N, Walker ES, et al. Acute Effects on Blood Pressure Following Controlled Exposure to Cookstove Air Pollution in the STOVES Study. J Am Heart Assoc. 2019; 8(14): e012246.
    CrossRefPubMed
  61. Unosson J, Blomberg A, Sandström T, et al. Exposure to wood smoke increases arterial stiffness and decreases heart rate variability in humans. Part Fibre Toxicol. 2013; 10: 20.
    CrossRefPubMed
  62. Corsini E, Budello S, Marabini L, et al. Comparison of wood smoke PM2.5 obtained from the combustion of FIR and beech pellets on inflammation and DNA damage in A549 and THP-1 human cell lines. Arch Toxicol. 2013; 87(12): 2187–2199.
    CrossRefPubMed
  63. Ceylan E, Kocyigit A, Gencer M, et al. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir Med. 2006; 100(7): 1270–1276.
    CrossRefPubMed
  64. Wang S, Chen Y, Hong W, et al. Chronic exposure to biomass ambient particulate matter triggers alveolar macrophage polarization and activation in the rat lung. J Cell Mol Med. 2022; 26(4): 1156–1168.
    CrossRefPubMed
  65. Fernandes L, Rane S, Mandrekar S, et al. Eosinophilic Airway Inflammation in Patients with Stable Biomass Smoke- versus Tobacco Smoke-Associated Chronic Obstructive Pulmonary Disease. J Health Pollut. 2019; 9(24): 191209.
    CrossRefPubMed
  66. Duan Jx, Cheng W, Zeng Yq, et al. Characteristics of Patients with Chronic Obstructive Pulmonary Disease Exposed to Different Environmental Risk Factors: A Large Cross-Sectional Study. Int J Chron Obstruct Pulmon Dis. 2020; 15: 2857–2867.
    CrossRefPubMed

Regulamin

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Wydawcą serwisu jest VM Media Group sp. z o.o, Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl